The surveillance regarding the ultra-rapid insulin glulisine (Apidra).
Latest Information Update: 12 May 2016
At a glance
- Drugs Insulin glulisine (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 09 Aug 2013 Planned initiation date changed from 1 Apr 2012 to 1 Aug 2013 as reported by University Hospital Medical Information Network - Japan
- 06 Mar 2012 New trial record